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Abstract
Helicobacter pylori colonizes the mucus niche of the gastric mucosa and is a risk factor for gastritis, ulcers and cancer. The
main components of the mucus layer are heavily glycosylated mucins, to which H. pylori can adhere. Mucin glycosylation
differs between individuals and changes during disease. Here we have examined the H. pylori response to purified mucins
from a range of tumor and normal human gastric tissue samples. Our results demonstrate that mucins from different
individuals differ in how they modulate both proliferation and gene expression of H. pylori. The mucin effect on proliferation
varied significantly between samples, and ranged from stimulatory to inhibitory, depending on the type of mucins and the
ability of the mucins to bind to H. pylori. Tumor-derived mucins and mucins from the surface mucosa had potential to
stimulate proliferation, while gland-derived mucins tended to inhibit proliferation and mucins from healthy uninfected
individuals showed little effect. Artificial glycoconjugates containing H. pylori ligands also modulated H. pylori proliferation,
albeit to a lesser degree than human mucins. Expression of genes important for the pathogenicity of H. pylori (babA, sabA,
cagA, flaA and ureA) appeared co-regulated in response to mucins. The addition of mucins to co-cultures of H. pylori and
gastric epithelial cells protected the viability of the cells and modulated the cytokine production in a manner that differed
between individuals, was partially dependent of adhesion of H. pylori to the gastric cells, but also revealed that other mucin
factors in addition to adhesion are important for H. pylori-induced host signaling. The combined data reveal host-specific
effects on proliferation, gene expression and virulence of H. pylori due to the gastric mucin environment, demonstrating a
dynamic interplay between the bacterium and its host.
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Introduction
Half of the world’s population is infected with the bacterium
Helicobacter pylori. 1–3% of infected individuals develop gastric
adenocarcinoma or MALT lymphoma and another 10–15%
develop gastritis or gastric and duodenal ulcers, whereas the
majority show no symptoms [1]. Adherence of H. pylori to the
gastric mucosa is highly relevant for the development of gastric
disease [2–4]. Only part of the colonizing H. pylori attaches directly
to epithelial cells [5]. Instead, most of them live in the mucus layer
of the superficial gastric mucosa where they can bind to the highly
glycosylated mucins [6,7]. The mucus layer in the stomach consists
mainly of the secreted mucins MUC5AC, produced from the
superficial mucosa, and MUC6, produced from the gland mucosa
[8]. The best characterized H. pylori adhesins are the blood group
antigen binding adhesin (BabA) that binds to Lewis b (Le
b) and H-
type 1 structures [9], and the sialic acid binding adhesin (SabA)
that binds to sialyl-Le
x and sialyl-Le
a [10]. The mucus layer
protects the gastric mucosa by acting as a physical barrier
preventing H. pylori from binding to the epithelia [7,11].
Furthermore, terminal 1,4-linked N-acetylglucosamine (a1,4-
GlcNAc), which is a carbohydrate structure on mucins present
in the gastric glands, has been demonstrated to have antimicrobial
activity [12], which may contribute to protection against H. pylori
colonization of the gastric glands.
In H. pylori infection, precancerous lesions and cancer, the
expression, glycosylation and spatial distribution of mucins change
both in humans and in the rhesus monkey infection model [11,13–
17]. As a consequence, the H. pylori adhesion targets and the
glycan environment that H. pylori is exposed to can dramatically
change [7,11,17]. For example, in the rhesus monkey there are
time-dependent changes in the Le
b expression and induced
expression of sialylated Lewis antigens upon infection with H.
pylori [11], and in humans, high level of Le
a and sialylation is
associated with gastric tumors [16,18].
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on H. pylori during infection and associated disease is poorly
understood. Crude porcine gastric mucins have been shown to
stimulate proliferation of H. pylori [19,20], and antral surface
mucins from normal tissue of one gastric cancer patient stimulate
H. pylori proliferation [12]. In addition, the intestinal pathogen
Campylobacter jejuni responds to human MUC2 with decreased
proliferation and altered gene expression [21].
In this study, we investigated how H. pylori can be affected by
mucins from different individuals and disease states. We examined
the interactions between H. pylori and mucins regarding binding,
proliferation, gene expression and virulence of H. pylori when
exposed to purified mucins from a range of gastric mucosal
samples from healthy and gastric cancer affected individuals. We
found that mucins from different individuals could diversely
modulate H. pylori behavior in all these aspects, partly dependent
on mucin origin and H. pylori binding ability.
Results
Mucins isolated from different regions, individuals and
disease stages differ in glycosylation
We isolated mucins from normal gastric mucosa from healthy
individuals and gastric tumor tissue as well as normal gastric
mucosa from tumor-affected stomachs (Table 1). The mucin and
carbohydrate contents of the samples are summarized in Table 2.
The normal gastric mucosa isolated from tumor-affected stomachs
was divided into surface versus gland material and thereby
MUC5AC was separated from MUC6. Mucins were further
divided into those soluble and insoluble in guanidinium hydro-
chloride (GuHCl): Insoluble mucins were mainly MUC2, whereas
most of the MUC5AC and MUC6 were present in soluble
fractions. MUC2 was only found in tumor samples. Unlike
samples from macroscopically normal tissue, tumor mucin samples
contained sialyl-Le
x and sialyl-Le
a in concordance with previously
published results that sialylation of gastric tissue mucins is
associated with cancer [16]. The lack of MUC2, MUC5B,
superficial MUC6 and sialylation of non-tumor samples confirms
the pathologist’s report stating that these specimens were normal.
It has previously been reported that terminal a1,4-GlcNAc is co-
localized with MUC6 in the glands [22,23]. In agreement with
this, the mucins isolated from the gland mucosa contained more
a1,4-GlcNAc than mucins isolated from the superficial mucosa.
However, the tumor sample containing MUC6 did not contain
a1,4-GlcNAc (Table 2).
Proliferation of H. pylori varies in the presence of mucins
of different origin
H. pylori J99 wt was cultured in liquid media in the presence of
mucins samples to monitor effects of mucins on H. pylori
proliferation. The effects of all mucins were analyzed at a
concentration of 10 mg/mL, whereas fewer samples were analyzed
at higher concentrations since not all gastric specimens obtained
were of sufficient size to yield large amounts of mucins. Mucins
isolated from different individuals differed in their effect on H.
pylori proliferation (p#0.001, One-way ANOVA) and ranged from
86% inhibition to 121% increase in proliferation after 60 h culture
with 10 mg/mL mucin samples and from 76% inhibition to 175%
increase with 50 mg/mL of mucins (Figure 1). The effect on both
inhibition and stimulation of proliferation increased with higher
mucin concentrations (Figure 1, Figure 2A). At 50 mg/mL, H.
pylori proliferation was higher in the presence of tumor-adjacent
surface tissue mucins than with mucins from healthy stomachs
(Figure 2B). In general, mucins from healthy stomachs had no or
inhibitory effect, whereas mucins from diseased stomachs varied
greatly in their ability to affect H. pylori proliferation. The mucins
with the most stimulatory effect were isolated from tumor-adjacent
surface tissues and from one of the tumors (P1 TS). However, the
substantial variation within each group indicates that interindi-
vidual factors other than disease state are important.
H. pylori proliferation was higher in the presence of the
superficial mucins than with the gland mucins from the same
individual and stomach location in 2 of 4 cases after 37 h and in 3
of 4 cases after 60 h culture (Figure 2C and D). This is in line with
a previous study where gland mucins from one patient inhibited
proliferation due to the presence of a1,4-GlcNAc and superficial
mucins from the same patient stimulated proliferation [12].
However, the gland mucins from fundus did not inhibit
proliferation in our study even though they contain high amounts
of a1,4-GlcNAc. Mucin and mucin glycan content from healthy
stomachs were similar to that of mucins isolated from tumor-
adjacent surface tissue mucins. The difference in effect on
proliferation (Figure 2B) between these two groups of mucins are
thus not dependent on a1,4-GlcNAc.
Binding ability of H. pylori J99 varies between mucin
samples and mucins that induce most proliferation show
strong adherence to H. pylori
Similar to the proliferation response, H. pylori binding ability to
surface mucin samples was higher than that to gland mucin
samples from the same patient for most samples (Figure 3).
Binding correlated with the presence of MUC5AC and Le
b
(r=0.738, p#0.001 and r=0.516, p=0.024, Pearson’s correla-
tion), but not with sialyl-Le
x or sialyl-Le
a, in concordance with
previously published data demonstrating that H. pylori binds
mainly to MUC5AC-associated Le
b at neutral pH [6]. Mucins
isolated from healthy stomachs and tumors tended to be less
potent ligands for H. pylori J99 than mucins from tumor-adjacent
tissue, even when MUC5AC and Le
b amounts were similar. Thus,
the H. pylori binding ability of the mucins also varied depending of
uncharacterized individual differences, most likely relating to the
steric presentation of glycans. There was no binding to the
insoluble mucins isolated from the tumor samples (Figure 3), which
contain mainly MUC2 and no MUC5AC. The ability of H. pylori
to bind mucins seems to be associated to proliferation as most
mucin samples that bound to H. pylori tended to induce
proliferation (Pearson’s correlation between H. pylori binding and
proliferation level at 60 h with mucins at 50 mg/mL: r=0.562,
p=0.057).
In addition to the binding analyzed by the microtiter-based
assay, binding to mucins in the environment of the proliferation
assay as well as the bacterial viability was visualized with LIVE/
DEADH BacLight
TM bacterial viability staining. Alike most other
stimulatory mucin samples, H. pylori strain J99 wt cultured with the
patient 1 soluble tumor mucins showed aggregates of highly viable
mucin-binding H. pylori compared to the less aggregated H. pylori
without mucins (Compare Figure 4A and C). This indicates that
the patient 1 soluble tumor mucins bind strongly to H. pylori in the
soluble environment that the proliferation assay is performed in
even though binding to these mucins when attached to a microtitre
well surface (Figure 3) were intermediate/low. H. pylori J99 wt
cultured with inhibitory mucins showed less or no aggregating
bacteria and also showed a lower ratio of live bacteria with intact
membranes after 37 hours of culture (Figure 4E). These results
support that binding is involved in the proliferation response to
mucins and that some mucin samples act inhibitory on H. pylori.
Effects of Gastric Mucins on Helicobacter pylori
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Origin Patient number and sample type Short name Density (g/l)
Gastric tumor mucosa Patient 1 Tumor soluble P1 TS 1.39–1.43
Patient 1 Tumor insoluble (high density) P1 TI (hd) 1.40–1.44
Patient 1 Tumor insoluble (low density) P1 TI (ld) 1.36–1.38
Patient 2 Tumor soluble P2 TS 1.35–1.43
Patient 3 Tumor soluble P3 TS 1.35–1.45
Patient 4 Tumor soluble (high density) P4 TS (hd) 1.41–1.45
Patient 4 Tumor soluble (low density) P4 TS (ld) 1.33–1.39
Patient 4 Tumor insoluble P4 TI 1.32–1.48
Normal mucosa of tumor-affected
stomachs
Patient 5 Tumor-adjacent antrum surface P5 TA-AS 1.36–1.42
Patient 5 Tumor-adjacent antrum glands P5 TA-AG 1.34–1.41
Patient 6 Tumor-adjacent fundus surface P6 TA-FS 1.36–1.43
Patient 6 Tumor-adjacent fundus glands P6 TA-FG 1.36–1.42
Patient 6 Tumor-adjacent antrum surface P6 TA-AS 1.36–1.42
Patient 6 Tumor-adjacent antrum glands P6 TA-AG 1.38–1.42
Patient 7 Tumor-adjacent antrum surface P7 TA-AS 1.34–1.38
Patient 7 Tumor-adjacent antrum glands P7 TA-AG 1.36–1.42
Healthy gastric mucosa Patient 8 Healthy P8 Healthy 1.37–1.42
Patient 9 Healthy P9 Healthy 1.37–1.42
Patient 10 Healthy P10 Healthy 1.35–1.41
doi:10.1371/journal.pone.0036378.t001
Table 2. Content of mucins and glycan structures in isolated mucin samples.
Origin Sample MUC5AC MUC6 MUC2 MUC5B Le
b Sialyl-Le
x Sialyl-Le
a a1,4-GlcNAc
Gastric tumor mucosa P1 TS ++ + 2 ++ ++ ++ + 2
P1 TI (hd) 22 + 2 ++ ++ + 2
P1 TI (ld) 22 + 2 ++ + 22
P2 TS + 2 + 2 ++ + + 2
P3 TS + 222 ++ 22
P4 TS (hd) 22 + 2 ++ 22
P4 TS (ld) 22 + 2 ++ + 22
P4 TI 22 ++ 2 + 222
Normal mucosa of tumor-
affected stomachs
P5 TA-AS + 222 ++ 222
P5 TA-AG ++ + 22 ++ 22+
P6 TA-FS ++ 222 ++ 22+
P6 TA-FG ++ + 22 ++ 22++
P6 TA-AS + 222 ++ 22+
P6 TA-AG ++ 22 ++ 22++
P7 TA-AS ++ 222 ++ 222
P7 TA-AG ++ 22 ++ 22+
Healthy gastric mucosa P8 Healthy + 222 2 222
P9 Healthy + 222 ++ 222
P10 Healthy + 222 ++ 22+
The relative amount of mucins and glycan structures relevant for interactions with H. pylori were determined by ELISA. The relative presence or absence of each
structure is indicated with ++ (above 75% of the highest assay value), + and 2 (OD450 less than 0.15 for antibodies giving a high signal and 0.1 for antibodies giving a
low signal). Abbreviations of sample identity are explained in Table 1.
doi:10.1371/journal.pone.0036378.t002
Effects of Gastric Mucins on Helicobacter pylori
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b glycoconjugates induce more H. pylori proliferation
than sialyl-Le
x glycoconjugates
H. pylori J99 wt was cultured in the presence of Le
b and sialyl-
Le
x glycoconjugates to isolate the effect of these H. pylori ligands on
proliferation. The Le
b and sialyl-Le
x structures were presented as
hexamers, conjugated to human serum albumin (HSA) to provide
multivalency. H. pylori proliferation after culture with the Le
b
conjugate was increased compared to that of the HSA control and
sialyl-Le
x conjugate (Figure 5A, p#0.001, One-Way ANOVA).
Aggregation of bacteria occurred after culture with Le
b conjugate
(Figure 5D), whereas less and smaller aggregates were seen with
the sialyl-Le
x conjugate or in the control (Figure 5E and F,
respectively), supporting previously published data that H. pylori
J99 wt bound to the Le
b conjugate [24].
To more closely resemble the glycan presentation to that of
gastric mucins, H. pylori J99 wt was cultured with the recombinant
mucin-type glycoprotein P-selectin glycoprotein ligand-1 (PSGL-1)
with variable glycosylation expressed in CHO-K1 and yeast cells
[25–27]. A small difference in proliferation could be seen first after
3–4 days (Figure 5B). Similar to the results with HSA-
glycoconjugates, H. pylori proliferation was higher in the presence
of PSGL-1 with Le
b than PSGL-1 with sialyl-Le
x (Figure 5C).
Together these results indicate that the binding to Le
b, but not to
sialyl-Le
x, leads to an increase in proliferation. Both glycoproteins
containing sialic acid; with mono-and disialylated core 1 or with
sialyl-Le
x, gave slightly lower proliferation than that of H. pylori
cultured without glycoproteins, whereas there were no change in
proliferation with glycoproteins without sialic acid (Figure 5B).
However, neither HSA-glycoconjugates nor recombinant mucin-
type glycoproteins were able to induce as major changes in
proliferation as seen after culture with human mucin samples.
Other H. pylori strains also display a binding-dependent
proliferation response to mucins
To test whether the effect on mucins on H. pylori is relevant to
other strains, additional H. pylori strains with different mucin
binding capabilities were cultured in the presence of mucin
samples that showed stimulatory and inhibitory effects on J99 wt
proliferation. Strains CCUG17875/Le
b, HP 201 and HP 1172
which have a similar mucin binding ability as strain J99 wt [28],
Figure 1. Proliferation of H. pylori J99 in the presence of purified mucins. Proliferation of H. pylori J99 wt during 60 h in the presence of
mucins derived from: A) gastric tumor mucosa at 10 mg/mL (closed symbols=soluble mucins, open symbols=insoluble mucins), B) normal mucosa of
tumor-affected stomachs at 10 mg/mL (closed symbols=surface mucins, open symbols=gland mucins), C) healthy mucosa at 10 mg/mL, D) gastric
tumor mucosa at 50 mg/mL, E) normal mucosa of tumor-affected stomachs at 50 mg/mL and E) healthy mucosa at 50 mg/mL. Control without mucins
(PBS control) is shown in bold red. An OD560 of 0.1 corresponds to 10
7 CFU/mL.
doi:10.1371/journal.pone.0036378.g001
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tumor mucins (Table 3). The strains that in previous studies
showed little or no BabA-mediated binding to mucins (strains HP
364, J99DbabADsabA, 26695 and CCUG17874 [7,10,28]), did not
show increased proliferation in response to the patient 1 soluble
tumor mucins (Table 3). The J99 adhesin deletion mutant
J99DbabADsabA had a higher baseline proliferation and lower
proportional viability than its parent strain (Figure 4B). Micros-
copy studies of J99DbabADsabA verified the lack of binding to the
mucin sample (i.e. lack of bacterial aggregation after mucin
treatment) and also showed less viable bacteria after culture with
mucins (Figure 4D). Strain CCUG17874 bind to the patient 1
soluble tumor mucins via SabA and not BabA [7,28]. Therefore
the lack of increased proliferation in response to this mucin further
supports that binding to Le
b, but not to sialyl-Le
x, plays a role for
the proliferation response. In summary, the strains that bind
mucins via BabA (CCUG17875/Le
b, HP 201, HP 1172 and J99
wt) showed enhanced proliferation in culture with the stimulatory
mucin, whereas strains that do not have the BabA adhesin did not
(strains HP 364, J99DbabADsabA, 26695 and CCUG17874),
irregardless of if they carry the SabA adhesin or not. Thus, other
strains than J99 also respond to mucins by a change in
proliferation. The mucin binding ability via BabA seems to be
an important factor for enhancing the H. pylori proliferation in
response to mucins, whereas inhibition of proliferation in response
to the mucins that have an inhibiting effect appear to be
independent of adhesion to mucins.
Gene expression of H. pylori cultured with mucins co-
varies
As mucins differently affect H. pylori proliferation we hypoth-
esized that mucins also can modulate the expression of genes
involved in mucin binding and other virulence processes. H. pylori
response to mucins at the transcriptional level was analyzed by
real-time PCR and the expression of babA, sabA, flaA, cagA, and
ureA was normalized to the expression of 16S rRNA. Mucin
samples were able to modulate the expression of H. pylori J99 wt
genes at different extents (Figure 6A–E), but not for J99DbabAD-
sabA (Figure 6F). The genes babA, sabA and cagA from H. pylori J99
showed the same expression level pattern for each mucin sample
with intercorrelation between the genes (r=0.85–0.93, p#0.001),
which was also found between ureA and flaA (r=0.74, p=0.01,
Table 4) and which indicates that these genes are regulated by
common pathways in the response to mucins. None of the samples
that increase the babA expression were able to stimulate H. pylori
proliferation. The expression of babA and ureA correlated
Figure 2. Concentration- and tissue-dependency of purified mucins for H. pylori J99 proliferation. A) Concentration-dependency of one
stimulatory (P5 TA-AS, black closed symbols) and one inhibitory mucin sample (P7 TA-AG, blue open symbols) on H. pylori proliferation comparing
mucin concentrations of 125 (&), 50 (m) and 10 (.) mg/mL to proliferation without mucins (bold red &). (***p#0.001, One-way ANOVA, Dunnett t-
test, compared to J99 without mucins after 60 h proliferation.) B) H. pylori fold proliferation level compared to PBS control after 60 h with mucins
grouped by tissue type origin at 125, 50 and 10 mg/mL of mucin. (*p=0.046, One-way ANOVA, Tukey’s post hoc test.) C and D) H. pylori fold
proliferation level compared to PBS control after 37 h and 60 h with mucins from superficial (white bars) or gland (black bars) mucosal tissue from the
same individual. (***p#0.001, *p,0.05, ns=not significant, Student’s t-test.) Although the differences between gland and surface derived mucins
was larger at 60 h than at 37 h, some of the growth curves had lost their parabolic growth by this time, which explains why the results for one sample
is different at 60 h than at 37 h.
doi:10.1371/journal.pone.0036378.g002
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p,0.05), and the expression of cagA correlated negatively both to
proliferation and mucin binding (r=0.789, p,0.01 and r=0.639,
p,0.05). These results suggest that weak interactions to mucins
increase expression of H. pylori adhesin and virulence factors as
opposed to when there is high binding to mucins associated with
enhanced proliferation or when there is no binding to mucins.
Mucin-pretreatment of H. pylori inhibits binding to
gastric epithelial cells and protects their viability
Our results that both proliferation and gene expression can be
modulated by mucins indicate that mucins affect the virulence of
H. pylori. This was investigated by infecting an in vitro infection
model of confluent gastric MKN7 cells, mimicking the gastric
epithelial surface cell layer, with H. pylori pretreated with the
mucin samples. The mammalian cell culture conditions (RPMI
1640 with 10% FBS) supported concentration-dependent effects of
mucins on H. pylori proliferation similar to the effects in BHI with
10% FBS (Figure 7A). Patient 1 soluble tumor mucins inhibited
binding of H. pylori to MKN7 cells in a concentration-dependent
manner (Figure 7B). The metabolic activity (as measured with the
WST-1 reagent) of the MKN7 cells decreased after co-culture with
H. pylori and this decrease was partially restored when H. pylori was
pretreated with this mucin sample (Figure 7C). In line with these
results, the flow cytometry apoptosis assay (Annexin V/7AAD)
showed an increased number of live MKN7 cells and a decreased
number of apoptotic cells with higher concentration of the patient
1 soluble tumor mucins added to H. pylori precultures compared to
without mucins (Figure 7D). Inhibition of bacterial binding to the
cells by mucins thus protected their viability. Similarly, H. pylori
pretreated with the Le
b-HSA-conjugate inhibited H. pylori binding
to the cells and increased cell viability to a higher extent than the
sialyl-Le
x-HSA conjugate (Figure 7B and C). Although Le
b-HSA-
conjugate strongly inhibited H. pylori binding to the cells, it did not
protect the cell viability as much as patient 1 soluble tumor
mucins. Thus, limiting adhesion is not the only manner in which
mucins protect gastric epithelial cell viability during infection.
MKN7 cell viability after H. pylori infection was to different
degrees protected by all mucin samples when added (at 50 mg/mL)
to pre-cultures of H. pylori (Figure 8A). To a lesser degree, some of
the mucin samples inhibited H. pylori binding to MKN7 cells
(Figure 8B), but inhibition of H. pylori cell binding did not correlate
to the ability of the mucins to bind the bacteria (see Figure 3)
(r=20.137, p=0.725). The viability of the host cells is thus
affected by other pathogen factors, such as the herein demon-
strated mucin-induced changes in pathogen gene expression in
addition to that mucins bind up bacteria and prevent them from
adhering to the epithelial cells.
Mucin-pretreatment of H. pylori can modulate cytokine
production of gastric epithelial cells upon infection
Gastric epithelial MKN7 cells produced the pro-inflammatory
cytokines IL-6 and IL-8 (Figure 7E), but not IL-1b, IL-10, IL-
12p70 or TNF (data not shown), after infection with H. pylori J99.
Pretreatment of J99 wt with the Le
b conjugate resulted in a
decreased cytokine production (Figure 7E), reflecting less inflam-
matory response of the cells when fewer bacteria bind to the cells.
Supporting the role of bacterial binding for the cytokine response,
J99DbabADsabA, which bound less to MKN7 cells than J99 wt,
induced less IL-8 production from the host cells than J99 wt
(Figure 9A). Also, IL-8 production was dependent on the amount
of bacteria added to the cells and live bacteria was more potent in
inducing IL-8 compared to J99 wt culture supernatant (Figure 9B).
Thus, when the bacterial factors are kept constant, IL-8 secretion
increase with increasing H. pylori adhesion to the epithelial cells.
However, when H. pylori were pretreated with mucin samples,
Figure 3. Binding of H. pylori J99 to mucin samples. Binding of biotinylated H. pylori J99 to mucin samples was measured in a microtiter-based
assay. The presence or absence of Le
b and sialyl-Le
x in each mucin samples, as described in Table 2, is indicated below the x-axis.
doi:10.1371/journal.pone.0036378.g003
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binding (r=20.29-(20.15), p=0.38–0.71). Furthermore, pretreat-
ment of H. pylori with the patient 1 soluble tumor mucins resulted
in a gradual increase in production of both IL-6 and IL-8 with
increasing mucin concentration by infected MKN7 cells
(Figure 7E). If the level of adhesion to the host cells was the only
determining factor for cytokine production one would have
expected a decrease in cytokine production instead, as the mucin
pre-treatment decreased the level of adhesion in an incrementing
manner (Figure 7B). A higher IL-6 and IL-8 production was also
detected after infection with H. pylori pretreated with patient 4
soluble tumor mucins already at 10 mg/mL (data not shown) and
with three antral mucin samples at 50 mg/mL (Figure 8C). In
addition, low levels of IL-1b and IL-12 was detected after H. pylori
pretreatment with one of the mucin samples (patient 1 insoluble
tumor mucins, high density, at 125 mg/mL). Other mucins tested
did not interfere with the cytokine production (Figure 8C) and
MKN7 cells cultured with only mucins were unaffected. Thus,
although adhesion to host cells are of importance to induce host
cell inflammatory signaling, mucins modulate this host cell
signaling by additional means than by affecting H. pylori adhesion
to its host.
Discussion
Many studies have focused on the host response to H. pylori, but
fewer studies have investigated how H. pylori is affected by the host
and in particular by the host mucins. Previous studies report
differences in mucin expression and glycosylation between
individuals, tissue location and disease status [11,13,16]. Here
we investigated how interindividual differences and infection
associated changes in mucins, the building blocks of the mucus
niche that H. pylori resides in and also the host’s first line of
defense, affect H. pylori. We show that these differences can change
the interactions with H. pylori, causing modulations in proliferation
and gene expression as well as alterations in how the bacteria
affects the viability of host cells and host cell signaling. The
regulation of H. pylori by mucins may be an important explanation
for individual variations in host response and symptoms following
infection.
We show that mucin binding ability via BabA seems to be an
important factor for enhancing the H. pylori proliferation in
response to mucins, whereas inhibition of proliferation in response
to the mucins that have an inhibiting effect appears to be
independent of adhesion to mucins. A previous study on bacterial
growth in response to mucins showed that MUC2 inhibits
proliferation of C. jejuni [21], which the authors suggest may be
caused by adhesion of mucin oligosaccharide ligands to the
bacterium, creating a physical barrier that limits its capability to
obtain nutrients. Other studies have shown that porcine gastric
mucin increases the growth of both H. pylori and E. coli [19,20,29],
and Jiang et al. hypothesized that the increased H. pylori growth is
due to mucin binding and thereby protection against the
surrounding environment when bacteria are gathered around
mucins [20]. We also think that aggregation of H. pylori around
mucins would protect from the surrounding environment, both
from the oxygen dissolved in culture media and from harmful acid,
enzymes and immune factors in the gastric mucus layer. However,
signaling between bacteria or between mucins and bacteria could
also result in various responses affecting proliferation. Indeed, high
cell density of H. pylori has been shown to benefit their proliferation
[30], indicating bacteria-bacteria signaling when gathered around
mucins to play a role for proliferation rates. The variation in
bacterial cell density due to different growth rates of H. pylori
strains may influence the degree of the effect mucins can have on
proliferation after a certain culture time, as the ratio of bacteria to
mucin will differ and bacteria may be differently susceptible at
different growth rates.
Mucins are heavily glycosylated with a vast number of different
glycans with unknown functions. The differences between how
strains are affected by the same mucin sample are also explained
by that the binding affinity of the adhesins can vary in their ability
to recognize ligands depending on glycocontext and structural
presentation [6,31]. Moreover, adhesin repertoire differs between
strains and only strains that bind via BabA and not the strain
binding via SabA responded with a higher proliferation to the
patient 1 soluble tumor mucins, which contain both Le
b and sialyl-
Le
x. The effect of the H. pylori ligands Le
b and sialyl-Le
x could be
separately studied by co-cultures with glycoconjugates and
recombinant mucin-type glycoproteins. The BabA ligand Le
b
but not the SabA ligand sialyl-Le
x was able to induce a small,
albeit statistically significant increase in H. pylori proliferation. The
lack of large effects on H. pylori proliferation from glycoconjugates
and recombinant glycoproteins could depend on glycocontext and
presentation of the ligands, and that the carbohydrate content is
much lower; 20–30% of the total molecular weight for HSA-
glycoconjugates and around 40% for recombinant glycoproteins
[32], compared to around 80% for mucins [33], resulting in less
effect of multivalency and in total less glycans that can interact
with H. pylori. However, even when we (over)compensate for
differences in total glycan amounts by comparing recombinant
protein/HSA-glycoconjugate at 50 mg/mL to human mucins at
Figure 4. Aggregation and viability of H. pylori J99 after culture
with mucins. H. pylori were stained with LIVE/DEADH BacLight
TM
bacterial viability staining after 37 h culture with or without 50 mg/mL
of mucin samples. Green represents bacteria with intact membranes
and red represents dead bacteria or bacteria with damaged mem-
branes. The percentages of live bacteria are noted in each picture. A)
J99 wt with PBS, B) J99DbabADsabA with PBS, C) J99 wt with patient 1
soluble tumor mucins, D) J99DbabADsabA with patient 1 soluble tumor
mucins and E) J99 wt with patient 10 healthy gastric mucins.
doi:10.1371/journal.pone.0036378.g004
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human mucins.
The mechanism for effects of proliferation might not only be
due to mucin binding as there are variations of the degree of
stimulation not fully explained by binding ability. Kawakubo et al.
show that a1,4-GlcNAc have antimicrobial affect on H. pylori [12].
Our results show that gland-derived mucins contain various
amounts of this glycostructure and that some of the gland-derived
mucins inhibit proliferation. However, there were also mucin
samples that did not inhibit the proliferation although they
contained a1,4-GlcNAc and most strains tested were either not or
just slightly inhibited by gland mucins containing a1,4-GlcNAc. As
we conclude that mucins enhance H. pylori proliferation and gene
expression in an adhesion dependent manner, the total effect on
H. pylori proliferation is likely to be the combined effects of mucins
on gene expression, enhancing proliferation ability and antimi-
crobial effects of the a1,4-GlcNAc structure and there may be yet
further mechanisms to be revealed.
There are two alternatives for how mucins can alter the growth
curve of H. pylori: Either mucins can affect the length of the lag
phase or the generation time at log phase. With most mucins in
our experiment, H. pylori lag phase lasts 15 h similar as without
mucins (Figure 1). The most exponential growth occurs between
20 and 40 h from start of experiment and at this time frame the
growth curve slope of H. pylori with stimulatory mucins is steeper
than that without mucins (Figure 1). Thus it seems that it is
primarily the generation time that is altered by the interaction with
mucins.
Figure 5. Proliferation of H. pylori J99 in the presence of HSA-glycoconjugates and recombinant mucins. A) Proliferation of H. pylori J99
wt cultured with 50 mg/mL of Le
b or sialyl-Le
x glycoconjugate and HSA control. B) Proliferation of H. pylori J99 wt cultured with 50 mg/mL of
recombinant PSGL-1. CM=unmodified CHO-K1 PSGL-1 containing mono- and disialylated core 1, CM-SLe
x=sialyl-Le
x substituted PSGL-1, CM-
Le
b=Le
b substituted PSGL-1, CM-A=blood group A active PSGL-1 and PPM=mannose-containing PSGL-1 lacking sialic acid produced in the yeast
Pichia pastoris. C) Fold proliferation level of H. pylori J99 wt in the presence of HSA-glycoconjugates compared to HSA control after 37 h and
recombinant PSGL-1 compared to PBS control after 115 h. ***p#0.001, *p,0.05, Student’s t-test. D-F) Bacteria were stained with LIVE/DEADH
BacLight
TM bacterial viability kit after culture with D) HSA-Le
b conjugate, E) HSA-sialyl-Le
x conjugate and F) HSA control. Green represents bacteria
with intact membranes and red represents dead bacteria or bacteria with damaged membranes.
doi:10.1371/journal.pone.0036378.g005
Table 3. Proliferation of different H. pylori strains in the
presence of two mucin samples.
P1 tumor soluble P7 TA antrum gland
J99 wt 206618*** 7665***
J99DbabADsabA 105610 8966***
26695 99625 99614
CCUG17874 100679 3 65*
CCUG17875/Le
b 11066** 8565***
HP201 436627*** nd
HP364 87611 nd
HP1172 15666n d
Effect of mucins (50 mg/mL) on proliferation of different H. pylori strains
expressed as percentage of proliferation without mucins. (***p#0.001,
**p,0.01, *p,0.05, Independent Student’s t-test, nd=not determined).
doi:10.1371/journal.pone.0036378.t003
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up-regulation (but never a down-regulation) of genes important in
colonization and virulence processes. Changes in expression levels
of different genes in response to the mucin samples correlated,
indicating that some of the genes are regulated by the same
pathways. All of the genes mentioned play a role in colonization
and pathogenesis processes and a simultaneous up-regulation of
these genes, as seen after culture with some of the mucin samples,
may result in higher virulence of the bacteria. Expression levels of
cagA correlated with decreased viability of host cells showing that
some mucins can indeed induce virulence of H. pylori.
Expression of cagA correlated negatively to both proliferation
and mucin binding. Similarly, babA expression was increased only
in samples that do not stimulate proliferation and that, except
from one sample, showed weak binding to H. pylori. Expression of
babA and cagA correlated well in our experiments using one strain
and variable external stimulation, and these genes have previously
been shown to correlate in clinical isolates between different H.
pylori strains [34]. Perhaps, when there is a low-degree of binding
to mucins, H. pylori compensate by producing more BabA and
Figure 6. Gene expression of H. pylori in response to mucins. A–E) The gene expression of cagA, ureA,b abA, sabA and flaA of H. pylori J99 wt
cultured in the presence of 50 mg/mL mucin samples derived from tumor tissue (black bars), normal mucosa of tumor-affected stomachs (grey; filled
bars=surface mucins, striped bars=gland mucins) and healthy mucosa (white bars). Expressions are shown as fold expression to H. pylori cultured
without mucins, normalized to 16S rRNA. A fold expression difference greater than 4 is considered significant. F) J99DbabADsabA fold expression of
cagA and ureA.
doi:10.1371/journal.pone.0036378.g006
Table 4. Correlation between gene expression levels.
babA sabA cagA flaA
babA Pearson Correlation 1
p-value
sabA Pearson Correlation 0.934 1
p-value 0.000
cagA Pearson Correlation 0.851 0.914 1
p-value 0.001 0.000
flaA Pearson Correlation 0.405 0.199 0.302 1
p-value 0.216 0.557 0.366
ureA Pearson Correlation 0.601 0.535 0.665 0.736
p-value 0.050 0.090 0.026 0.010
Correlation of expression of virulence genes in H. pylori J99 co-cultured with
different mucin preparations.
doi:10.1371/journal.pone.0036378.t004
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successful long-term infection. Mucins may not up-regulate cagA
expression in J99DbabADsabA either because binding interaction to
the mucins is needed, even just to a low degree, to elicit the
response or because BabA is involved in the regulation of cagA
expression. A strong mucin binding also do not increase babA
expression and may not be favorable as bacteria then can be
washed away along with shedding mucins. Indeed, Rhesus
monkeys with mucins that bind H. pylori better have lower
infection density than monkeys having mucins with less BabA-
ligands [11]. It has also been reported that low producers of BabA
are associated with more severe clinical outcomes compared to
high producers and BabA-negative strains [2]. At first glance,
these studies may seem contrasting to our results that more mucin
Figure 7. Effects on mucin concentration and host cell adhesion on viability and cytokine production after infection. A) H. pylori J99
wt proliferation with patient 1 soluble tumor mucins and 50 mg/mL glycoconjugates after 24 h culture in RPMI 10% FBS, prior to MKN7 infection,
expressed as fold change from start of culture. B) Binding of H. pylori to MKN7 cells after 24 h infection expressed as percentages less binding than
untreated H. pylori. C) Viability of MKN7 cells measured by cell metabolic activity (WST-1 assay) after 24 h infection. Data are shown after subtracting
the small signal produced by the presence of bacteria in the assay. D) Percentage of live, early and late apoptotic cells after 24 h infection measured
by flow cytometry (Annexin V/7AAD). E) Concentration of IL-6 and IL-8 in cell culture media after 24 h infection (One out of two experiments carried
out at different concentrations with similar results are shown). (***p#0.001, **p,0.01, *p,0.05, ANOVA, Dunnett t-test, compared to J99 without
mucins or with HSA control. Independent Student’s t-test was used to compare between Le
b and sialyl-Le
x glycoconjugates.)
doi:10.1371/journal.pone.0036378.g007
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lead to higher infection density and more severe symptoms.
However, mucins appear able to bind up also the resulting higher
number of H. pylori, as is indicated by our observations of
aggregation of bacteria around the proliferation-stimulating
mucins and the increased inhibition of host cell binding
simultaneously as increased H. pylori proliferation with higher
concentration of proliferation-stimulating mucins, which protected
host cell viability (see Figure 7A–C).
Previously published results suggest that BabA-mediated
binding to the host cells facilitates translocation of CagA, which
triggers a cytokine response [4]. Likewise, our data show that when
the bacterial factors are kept constant, adhesion to host cells
increases the cytokine response. As CagA has been shown to be
important for IL-8 secretion, decreased production of CagA
associated with increased proliferation in response to mucins
further adds to the discrepancy with increased, instead of
decreased cytokine secretion after mucin pre-treatment. Although
the viability of host cells is protected by mucins that inhibit H.
Figure 8. Host cell adhesion, viability and cytokine production after infection with H. pylori pretreated with different mucins. A)
Viability of MKN7 cells measured by the cell proliferation reagent WST-1 after 24 h infection with H. pylori pretreated with mucin samples derived
from tumor tissue (black bars), normal mucosa of tumor-affected stomachs (grey; filled bars=surface mucins, striped bars=gland mucins) and
healthy mucosa (white bars), compared to controls without mucins (black and white bars). B) Binding of H. pylori to MKN7 cells after 24 h infection
expressed as percentages less binding than untreated H. pylori. C) Concentration of IL-6 and IL-8 in cell culture media after 24 h infection (One out of
two experiments carried out at different concentrations with similar results are shown). (***p#0.001, **p,0.01, *p,0.05, ANOVA, Dunnett t-test,
compared to MKN7+J99 without mucins.)
doi:10.1371/journal.pone.0036378.g008
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response to H. pylori. This indicates that the host cells also can
respond to unbound bacteria, but then without a major decrease
in viability, and that the response is mediated through H. pylori
factors affected by mucins other than CagA.
There seems to be a balance act between mucins trying to
protect the host cells and H. pylori trying to adapt to the
environment and mucins from most individuals induce some
effects on H. pylori that appear protective for the host and some
effects that appear harmful. Few mucin samples clearly tip the
effect on H. pylori towards either protective or virulence-inducing.
The patient 1 soluble tumor mucin seems to be the mucin sample
inducing most virulence; increasing H. pylori proliferation, cagA
expression and host cell cytokine production and showing
relatively low ability of inhibiting host cell binding and protecting
viability. If these effects contributed to tumor development or is a
consequence thereof is unclear. Mucins that inhibit H. pylori
proliferation, i.e. the mucins from glands and healthy tissue in our
study, seem to be most efficient in protecting the host, as this
would lead to fewer colonizing bacteria and as the damaging affect
on H. pylori results in less host cell binding and protection of host
cell viability. The inhibiting effects of some gland mucins may be a
contributing factor to the low levels of H. pylori colonization found
in gland mucosa [12], however, as all gland derived mucins in the
present study did not have this effect there are likely additional
reasons for lack of H. pylori colonization of the mucosal glands. The
mucins isolated from healthy tissue either may result in more
resistance to H. pylori or they have just not been modified by
infection, as H. pylori infection may induce changes on mucins that
are more favorable for colonization than the mucins in the healthy
uninfected stomach. However, our study contained too few
samples from either disease state to draw any firm conclusions
regarding differences of effects on H. pylori by mucins from cancer-
affected versus healthy stomachs.
To control for the possibility that we were not able to remove all
GuHCl used in the purification of the mucins by dialysis, we also
analyzed the effects of dialyzed 8 M GuHCl on the parameters,
and found that at high concentrations this control also had some
inhibiting effects on H. pylori proliferation and protected host cell
viability, but not on the other parameters. However, most samples
contained high concentrations of mucins and thereby the dialyzed
samples were diluted to the extent that we did not detect any
effects of the 8 M GuHCl dialysis control. The samples that had a
low concentration of mucins and thereby were diluted so little that
they may contain enough traces of GuHCl to have an effect on H.
pylori was sample P10 and P6 TA-AS when used at 50 mg/mL.
However, although sample P6 TA-AS should contain more
GuHCl traces than the other samples it still stimulated
proliferation of H. pylori J99 and the effect of mucins on H. pylori
proliferation thus can exceed an effect of GuHCl.
In conclusion, mucins derived from individuals with or without
gastric cancer affect H. pylori proliferation and gene expression, as
well as interactions with host cells. Our results demonstrate a
dynamic interplay between the bacterium and its host. Disease-
dependent differences may occur, but our main conclusion is that
there are differences between how mucins from different
individuals affect H. pylori. Host-specific effects on H. pylori may
explain the large individual differences in sensitivity to this
infection and mucins thus have the potential of being active
determinants of disease outcome.
Materials and Methods
Ethics statement
Gastric specimens were obtained after informed consent and
approval of local ethics committees (IMIM-Hospital del Mar,
Barcelona, Spain and Lund University Hospital, Lund, Sweden).
For recently collected specimens, we have written informed
consent statements, but some specimens were collected in 1996,
i.e. over 15 years ago, at other institutions than where we are
active and some individuals responsible for the collection are now
retired. We were therefore not able to locate the patient consent
forms for all patients in the study. We know that the specimens
were collected after informed consent and after approval of the
ethics committees as the individuals who were responsible for
collecting these samples have written that in the statements of
previously published articles using these samples (i.e. [6]).
Isolation of mucins
Mucins were isolated from archived gastric specimens. Four of
the specimens were from gastric adenocarcinoma tumors (intes-
tinal type) and another four were from macroscopically normal
mucosa of tumor-affected stomachs, as evaluated by a clinical
pathologist. These specimens of normal gastric mucosa isolated
from tissues adjacent to tumors were sufficiently large to allow this
material to be divided, prior to mucin isolation, into surface versus
Figure 9. IL-8 production in response to H. pylori infection is concentration and adhesion dependent. A) Fold change of IL-8
concentration in cell culture media from MKN7 cells infected with H. pylori J99 wt and J99DbabADsabA (multiplicity of infection (MOI) of 5) compared
to uninfected cells. The ratio of host cell binding of J99DbabADsabA to J99 wt is indicated in blue. B) Fold change of IL-8 concentration after infection
with H. pylori J99 wt at a MOI of 5 and 1, and with H. pylori J99 wt supernatant, compared to uninfected cells.
doi:10.1371/journal.pone.0036378.g009
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gastric wall of patients who underwent elective surgery for morbid
obesity. They had no history of peptic ulcer disease, and their
stomachs were macroscopically normal at the time of operation.
Specimens (approximately 1.561.5 cm) were taken from fundus
and antrum of the stomach [6]. The samples are summarized in
Table 1. The mucins were isolated from tissue specimens after
rinsing, which removes the extracellular mucus layer, and the
mucins isolated thus comprise the intracellular mucins that have
not been degraded by extracellular processes. Mucins were
isolated by isopycnic density gradient centrifugation from these
materials as previously described [35]. Mucins soluble in
guanidinium hydrochloride (GuHCl) were separated from insol-
uble mucins, which were later solubilized by reduction and
alkylation of disulphide bonds. As the insoluble samples from non-
tumor tissue did not contain MUC2 or other mucins, these were
excluded from the study. Density gradient fractions of purified
mucin samples were analyzed for carbohydrates as periodate-
oxidisable structures in a microtiter-based assay as previously
described (Figure 10) [28] and sialic acid was detected using an
automated periodate-resorcinol method [36]. Density measure-
ments were performed using a Carlsberg pipette as a pycnometer
and DNA was detected by UV light absorbance at 280 nm.
Preparation of mucin samples
Gradient fractions containing mucins were pooled together to
obtain one sample for each specimen (Table 1, Figure 10).
Gradients containing separated groups of fractions with different
mucin and carbohydrate content were pooled into two samples
(example in Figure 10A). All samples were dialyzed in phosphate
buffered saline (PBS) to remove guanidinium hydrochloride and
cesium chloride (CsCl) from the medium. Mucin concentration in
pooled samples was determined by detection of carbohydrate as
periodate-oxidisable structures in a microtiter-based assay: Flex-
ible 96-well plates (BD Biosciences, Franklin Lakes, NJ, USA) were
coated with mucin sample and left overnight at 4uC. After washing
three times with washing solution (5 mM Tris-HCl, 0.15 M NaCl,
0.005% Tween 20, 0.02% NaN3, pH 7.75), the carbohydrates
were oxidized by treatment with 25 mM sodium metaperiodate in
0.1 M sodium acetate buffer, pH 5.5 for 20 min in room
temperature. The plates were washed again and the wells were
blocked with DELFIA blocking solution (50 mM Tris-HCl,
0.15 M NaCl, 90 mM CaCl2,4mM EDTA, 0.02% NaN3,6 %
sorbitol, 0.1% BSA, pH 7.75) for 1 h. After further washing steps,
the samples were incubated for 1 h with 2.5 mM biotin hydrazide
in 0.1 M sodium acetate buffer, pH 5.5, followed by washing
again. Europium-labeled streptavidin was diluted 1:400 in assay
buffer (50 mM Tris-HCl, 0.15 M NaCl, 20 mM DTPA, 0.01%
Tween 20, 0.02% NaN3, 1.5% BSA, pH 7.75) and was added to
the wells. After 1 h incubation, the plates were washed six times
and then incubated with enhancement solution (0.05 M NaOH,
0.1 M ftalat, 0.1% Triton X-100, 50 mM TOPO, 15 mM b-NTA)
for 5 min on a shaker. The plates were measured using Wallac
1420 VICTOR
2 plate reader with the Europium label protocol
(PerkinElmer, Waltham, MA, USA). The concentrations were
calculated from a standard curve of a fusion protein of MUC1,
16TR and IgG2a Fc starting at a concentration of 20 mg/mL and
using seven 1:2 serial dilutions [37]. This method of concentration
determination was chosen as all mucins do not come into solution
after freeze drying, and determining concentration by freeze
drying therefore can contain large errors as well as remove mucin
species selectively.
Enzyme-linked immunosorbent assays
Mucins and carbohydrates in separate gradient fractions were
detected by antibodies in enzyme-linked immunosorbent assays
(ELISA) as described previously [28]. Pooled mucins gradient
samples were analyzed for the relative content of Le
b, sialyl-Le
a,
sialyl-Le
x, a1,4-GlcNAc, MUC5AC, MUC6, MUC2 and
MUC5B. Mucin samples were diluted in 4 M GuHCl to 6 mg/
mL for the glycosylation analysis or to 3 mg/mL for the mucin
analysis and coated on to 96-well polysorb plates (NUNC A/S,
Roskilde, Denmark) over night at 4uC. The samples to be analyzed
with LUM6-3, LUM2-3 and LUM5B-2 were reduced with 2 mM
1,4-dithiothreitol in 6 M GuHCl, 5 mM sodium EDTA, 0.1 M
Tris-HCl buffer, pH 8.0, at 37uC for 1 h and alkylated in 5 mM
iodacetamide at room temperature for 1 h in the dark to expose
the epitopes. All plates were washed 3 times with PBS 0.05%
Tween (washing buffer) and the wells were blocked for 1 hour with
Blocking Reagent for ELISA containing 0.05% Tween (blocking
buffer) in room temperature. After discarding the blocking buffer,
the plates were incubated for 1 hour with primary antibody for
glycan structure; Seraclone anti-Le
b (clone LE2, Biotest, Dreieich,
Germany), anti-sialyl-Le
a (clone CA19-9, NeoMarkers, Freemony,
CA, USA), anti-sialyl-Le
x (AM3, gift from Dr C. Hanski,
University Medical Center Charite ´, Berlin, Germany) diluted to
1 mg/mL, 1:200, 1:1000 and 1:20, respectively, and anti-a1,4-
GlcNAc (HIK1083, Kanto Chemical Co., Inc.,Tokyo, Japan)
Figure 10. Isolation of mucins from gastric tissue. Panels show carbohydrate, MUC5AC and MUC2 content in density gradient fractions diluted
1:500. The fractions for all samples were pooled based on this type of graphs, and in these graphs the pooled fractions are indicated by brackets. A)
Density gradient of the patient 1 insoluble tumor mucin sample, which is pooled into two samples with most MUC5AC in the high density sample
and most MUC2 in the low density sample. B) Density gradient of the patient 6 tumor-adjacent antrum surface sample.
doi:10.1371/journal.pone.0036378.g010
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Aldrich, St. Louise, MO, USA) diluted 1:8000 and anti-MUC6
(LUM6-3) [35], anti-MUC2 (LUM2-3) [38] and anti-MUC5B
(LUM5B-2) [39] diluted 1:2000 in blocking buffer. The plates
were again washed 3 times and then incubated for 1 hour with
0.8 mg/mL horse radish peroxidase (HRP) conjugated anti-mouse
IgM, anti-mouse IgG or anti-rabbit IgG (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA, USA) diluted in
blocking buffer. After further washing, tetramethylbenzidine
(TMB) substrate (EMD Biosciences, Inc., San Diego, CA, USA)
was added and the plates were monitored for color development.
The reaction was stopped with an equivalent amount of 0.5 M
H2SO4 and the absorbance at 450 nm was measured.
Bacterial culture conditions and strains
H. pylori strains were cultured on Brucella agar (Oxoid,
Basingstoke, Hampshire, England) supplemented with 10% bovine
blood, 1% IsoVitox (Oxoid), 4 mg/L Amphotericin B, 10 mg/L
Vancomycin and 5 mg/L Trimethoprim in 5% O2 and 15% CO2
at 37uC. Eight H. pylori strains/isogenic mutant with known
binding specificity were used in this study: H. pylori strains J99 wild
type (wt) bind Le
b and sialyl-Le
x, whereas the isogenic J99
adhesion mutant lacking the BabA and SabA adhesins (J99babA::
camsabA::kan, referred to as J99DbabADsabA), do not bind Le
b or
sialyl-Le
x [10] (kindly provided by Prof. Thomas Bore ´n, Umea ˚
University, Sweden). H. pylori 26695 also do not bind Le
b or sialyl-
Le
x, whereas CCUG17875/Le
b bind Le
b but not sialyl-Le
x and
CCUG17874 bind sialyl-Le
x but not Le
b [6] (kindly provided by
Prof. Susann Teneberg, University of Gothenburg, Sweden). The
clinically isolated strains HP201 and HP1172, but not HP364,
bind mucins positive for Le
b and sialyl-Le
x [28] (kindly provided
by Prof. Lars Engstrand, Swedish Institute for Infectious Disease
Control, Sweden).
H. pylori binding to mucins
Biotinylation of bacteria was performed as previously described
[6]. Binding of biotinylated H. pylori J99 wt to mucins samples were
assessed using a microtiter-based assay. Mucin samples were
diluted in 4 M GuHCl to 6 mg/mL and coated on 96-well
polysorb plates over night at 4uC. Subsequent steps were
performed as described previously [28]. The plates were washed
3 times with washing buffer and the wells were blocked for 1 hour
with blocking buffer. After discarding the blocking buffer,
biotinylated bacteria with an OD600 of 0.1 were diluted 1:20 in
blocking buffer, pH 7.5, and added to the plates, which then were
incubated in a bacterial shaker at 37uC for 2 hours. The plates
were washed 3 times and then incubated for 1 hour in room
temperature with blocking buffer containing 1 mg/mL of horse
radish peroxidase conjugated streptavidin. After further washing
steps, TMB substrate was added and the plates were incubated for
25 min. The reaction was stopped with an equivalent amount of
0.5 M H2SO4 and the plates were read in a microplate reader at
450 nm after color stabilization.
Proliferation assay
H. pylori were harvested from Brucella plates into PBS. Harvested
bacteria at an OD600 of 0.3 were cultured in brain heart infusion
medium (BHI) with 10% fetal bovine serum (FBS) with purified
and dialyzed mucin samples diluted in PBS at 10, 50 and 125 mg/
mL of mucin. H. pylori were also culture with 50 mg/mL of
glycoconjugates of the carbohydrate structures Le
b and sialyl-Le
x
coupled to human serum albumin (HSA) to create multivalency
(IsoSep AB, Tullinge, Sweden) or with 50 mg/mL of the
recombinant mucin-type glycoprotein P-selectin glycoprotein
ligand-1 (PSGL-1) produced in CHO-K1 cells; unmodified
CHO-K1 mucin containing mono- and disialylated core 1 (CM),
sialyl-Le
x substituted mucin (CM-SLex), Le
b substituted mucin
(CM-Leb) and blood group A active mucin (CM-A) [26,27], and
with a mannose-containing mucin lacking sialic acid produced in
the yeast Pichia pastoris (PPM) [25]. A control for normal
proliferation was obtained by adding only PBS without mucins, or
HSA (Sigma) without conjugates, to the culture medium, and a
control for efficient removal of toxic material in dialysis was
obtained by adding dialyzed guanidinium hydrochloride diluted in
PBS to the culture medium. Bacteria were cultured in a total
volume of 100 mL in 96-well plates, 12 to 18 replicates, for 24 or
60 hours at 37uC under aerobic conditions (10% CO2). The
strains used in this study grow well both at microaerobic and
aerobic conditions. Optical density (OD) at 560 nm was measured
at time points throughout the culturing. At the end of the
incubation, bacteria from a subset of wells were cultured on
Brucella plates and the number of colony forming units (CFU) was
calculated after 5 days of incubation. The CFU counts obtained
were proportional to the optical density at 560 nm, and therefore,
OD at 560 nm is presented in the graphs.
Fluorescence microscopy
For visualization, H. pylori were stained with a LIVE/DEADH
BacLight
TM bacterial viability kit (Molecular Probes, Leiden, The
Netherlands) according to the manufacturer’s directions. Bacteria
from two replicate wells were pooled after 37 h proliferation with
mucin samples or glycoconjugates and washed twice with 0.85%
NaCl and centrifuged at 2500 g for 3 min between the washes.
Washed pellets were resuspended with 100 mL 0.85% NaCl and
incubated with 0.3 mL premixed staining components for 15 min
in the dark. Stained bacteria were applied to a microscopy slide
and studied immediately under a fluorescence microscope for red
and green fluorescence simultaneously.
RNA extraction and cDNA synthesis
After 24 h of proliferation in the presence of mucins, bacterial
replicates were pooled into microcentrifuge tubes, centrifuged at
3000 g for 4 min and resuspended in RNAlaterH (Applied
Biosystems, Foster City, CA, USA). The samples were incubated
over night at 4uC and then stored at 220uC. Bacteria stored in
RNAlaterH were centrifuged at 5000 g for 5 min. The pellet was
resuspended with 100 mL of 400 mg/mL lysozyme in TE buffer
(1 mM EDTA, 10 mM Tris, pH8) and incubated at room
temperature for 5 min. RNA extraction was continued with
Qiagen’s RNeasy kit (Qiagen GmbH, Hilden, Germany),
including DNase treatment with Qiagen’s RNase-Free DNase
Set. Extracted RNA was eluted in 30 mL RNase-free water, and
stored at 270uC. Concentration of RNA was determined by
measuring the optical density at 260 nm with a spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). cDNA was
synthesized from 400 ng RNA using Quantitect Reverse Tran-
scription kit (Qiagen). Each sample was DNase treated (included in
the kit) and divided into two aliquots, one was used to transcribe
cDNA while the other was used as the reverse transcription
negative control in the subsequent real-time PCR assays. The
reverse transcription PCR protocol followed two steps: reverse
transcription for 15 min at 42uC and inactivation of enzyme for
3 min at 92uC. The reaction was carried out in a total volume of
20 mL: 7 mL sample containing 400 ng RNA together with 1 mL
random hexamer primers, 1 mL reverse transcriptase (RT), 4 mL
RT buffer and 7 mL water (nucleotide, DNase, and RNase free) or
with just 13 mL water in the negative control. cDNA was stored at
220uC.
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Gene sequences of H. pylori strain J99 (GenBank accession
number AE001439) were retrieved from the NCBI nucleotide
database (www.ncbi.nlm.nih.gov). Primer pairs were designed
using Primer3 web-based program (http://frodo.wi.mit.edu/
primer3/) with default settings. Gene specificity of primers was
confirmed using NCBI nucleotide BLAST. Previously described
primer sequences were used for cagA, flaA, ureA [40]. All primer
sequences used are listed in table 5.
Real-time PCR
Real-time PCRs were run in 96-well plates (Applied Biosys-
tems), in a total volume of 20 mL containing 10 mL SYBR green
real-time PCR master mix (Applied Biosystems), 10 pmol of each
primer, 6.5 mL water and 1.5 mL of a sample. Reverse
transcription negative controls and non-template controls were
included in each run. Amplification was performed using an
ABI7500 real-time PCR instrument (Applied Biosystems) with
default settings for the amplification protocol and including a
dissociation step in the end of the program for melting
temperature (Tm) analysis to confirm amplification specificity.
Expression was calculated with 2
2DCt and normalized against the
16S rRNA expression. Results are shown as fold-changes of
mRNA expression in samples relative to mRNA expression levels
in bacteria cultured without mucins. An expression difference of
more than 4 fold from the PBS-treated control bacteria is regarded
as an up- or down-regulation.
MKN7 cell culture and infection with mucin treated H.
pylori
The gastric epithelial cell line MKN7 is well-differentiated and
form firmly adherent continuous cell layers expressing MUC1 on
the apical side [24,41,42]. MKN7 cells were cultured in RPMI
1640 (Lonza, Verviers, Belgium) containing 10% FBS, 100 units/
mL penicillin G sodium and 100 mg/mL streptomycin. The
medium was changed to antibiotic-free medium 24 h prior to
infection experiments. The cells were incubated at 37uC and 5%
CO2. Prior to infection, MKN7 cells were seeded at a density of
4610
4 cells/well in 96-well plates and incubated for 3 days, at
which time point they were confluent. H. pylori J99 wt was cultured
for 24 h in 100 mL antibiotic-free cell culture medium in the
presence of mucins prepared as above. The media on the
confluent MKN7 cells was substituted with the media containing
mucin-treated H. pylori at a density of 3610
5 bacteria/well
(multiplicity of infection (MOI) of 5). The MKN7 H. pylori co-
culture was incubated for 24 h. All incubations were performed at
37uC in aerobic conditions.
Cell viability and apoptosis assays
The viability of MKN7 cells infected with H. pylori was
evaluated using the WST-1 cell proliferation assay (TaKaRa Bio
Inc.,Otsu, Shiga, Japan) measuring metabolic activity. Half of the
media was transferred to other 96-well plates to be measured as
the background from media and bacteria not attached to the cells.
Both plates (with and without MKN7 cells) were incubated with
4.5 mL/well of WST-1 reagent for 1 h at 37uC. The plates were
put on a shaker for 1 min and then measured at 450 nm in a
microplate reader. The values for the MKN7 cells were reduced
with the background values from the bacteria, which ranged from
20.004 to 0.02. Cell viability was also analyzed by flow cytometry
using Annexin V-PE Apoptosis Detection Kit No. 1 (BD
Pharmingen) according to the manufacturer’s instructions. For
this experiment, non-adherent cells in the media and attached cells
harvested with trypsin from four replicates were pooled to one
sample.
Assessment of mucin-treated H. pylori binding to MKN7
cells
Infected MKN7 cells used for the WST-1 assay were
subsequently washed three times with PBS, fixed with 4%
formaldehyde for 10 min on ice, and then incubated with 70%
ethanol at 4uC over night. The plates were washed 3 times with
washing buffer and the wells were blocked for 1 hour with
blocking buffer in room temperature. To detect bound bacteria,
the plates were then incubated for 1 hour with rabbit anti-H. pylori
serum (kindly provided by Prof. Thomas Bore ´n, Umea ˚ university,
Sweden) diluted 1:1500 in blocking buffer. The plates were again
washed 3 times and then incubated for 1 hour with HRP
conjugated anti-rabbit IgG (Jackson ImmunoResearch Laborato-
Table 5. Primers used in real-time PCR.
Gene Full name Direction Sequence Reference
jhpr6 16S ribosomal RNA Forward TCGGATTGTAGGCTGCAACTC
Reverse CCGCAACATGGCTGATTTG
babA Blood group antigen binding adhesin A Forward GGAAGCGAAAGTTTGAGTGG
Reverse GAGAGGCTTAGCGGGACTTT
cagA Cytotoxin-associated gene A Forward TGATGGCGTGATGTTTGTTGA [40]
Reverse TCTTGGAGGCGTTGGTGTATT [40]
clpA ATP-dependent Clp protease A Forward TGGCTAAAGAATTGGCCTTG
Reverse AGGACTTCCGATGAGCTTTG
flaA Flagellin A Forward ATGACGGTGGCGGATTCTT [40]
Reverse GATAATCCCCATGCCGTCATT [40]
sabA Sialic acid binding adhesin A Forward GAGCGTTGCTTACGGTTGAG
Reverse CCCAACAAAACGCTACCACT
ureA Urease subunit A Forward TATGGAAGAAGCGAGAGCTGGTA [40]
Reverse GAGTGCGCCCTTCTTGCAT [40]
doi:10.1371/journal.pone.0036378.t005
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washing, TMB substrate was added and the reactions were
stopped with an equivalent amount of 0.5 M H2SO4 after equal
time of incubation. The plates were read in a microplate reader at
450 nm.
Cytokine analysis
Culture supernatant from 6 replicates of infected MKN7 cells
were pooled to one sample and diluted 1:10. Cytokine production
was quantified using the CBA Human Inflammatory Cytokines
Kit (BD Biosciences) according to the manufacturer’s instructions.
The samples were analyzed on a FACSCalibur
TM (BD Bioscienc-
es). In addition, IL-8 was analysed in supernatants from cell
cultures using the BD OptEIA Human IL-8 ELISA Set (BD
Biosciences) according to manufacturer’s instructions.
Statistics
Statistical analyses were performed using SPSS Statistics 17.0
(SPSS Inc, Chicago, IL, USA) software package. The level of
significance was set at p,0.05.
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